TSE:4568Pharmaceuticals
Daiichi Sankyo (TSE:4568) Earnings Growth Reinforces Bullish Narratives on Consistent Outperformance and Valuation
Daiichi Sankyo (TSE:4568) posted a 32.7% annual earnings growth over the last five years, with the most recent period showing an 11.8% rise in earnings. Looking ahead, earnings are forecast to grow by 14.05% per year alongside an expected 9.6% increase in revenue. This would notably outpace the broader Japanese market’s 4.5% annual revenue growth rate. With current net profit margins at 14.1% and a price-to-earnings ratio of 24.3x, investors find themselves weighing healthy profit growth...